AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2020
Oct 20, 2020
31046_dirs_2020-10-20_2c3b3979-0895-4e78-9df5-1ff0c6e13b0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-10-16
Reporting Person: Jacobson Allan Steven (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-10-16 | Common Stock | S | 5000 | $51.29 | Disposed | 3498 | Direct |
Footnotes
F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2020.
More from PTC THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Board/Management Information
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20